Advisory Board

  • YouTube
  • Instagram
  • Facebook
  • LinkedIn
  • Twitter
  • TikTok
  • Pinterest
Kathy Pritchard-Jones.png

Professor Kathy Pritchard-Jones

United Kingdom & Europe

Professor Kathy Pritchard-Jones is Professor of Paediatric Oncology at University College London (UCL) Great Ormond Street Institute of Child Health, London, UK and past President of International Society of Pediatric Oncology (SIOP) 2021-2022, is an internationally recognised expert in childhood kidney cancers and is preminant in the area of Wilms and Wilms research.with a particular emphasis on Wilms, where she has extensive experience of running multi-centre and international clinical trials and translational research. She also works with epidemiologists and healthcare data scientists for international benchmarking and outcomes research. She has a track record of enabling partnership working to deliver quality improvement in complex care and to accelerate research across both adult and childhood cancer services. Throughout her career she has been an active member of the work of the national Children’s Cancer and Leukaemia Group (CCLG), the International Society of Paediatric Oncology (SIOP) and SIOP Europe. She has published over 250 articles in the field of childhood cancer.

Professor Paul Grundy

Professor Paul Grundy

North America

Professor Paul Grundy has been on the faculty of the the Department of Pediatrics at the University of Alberta, Canada since 1988 and is currently an Emeritus Professor of Pediatrics and Oncology. His research career has focussed on Wilms tumour of the kidney, spanning the spectrum from basic molecular biology, to translational research to clinical trials. A legacy of his research program is the childhood renal tumours tissue bank which now harbors a variety of specimens from over 6000 patients and is available to researchers worldwide. He has served as the Chair of the National Wilms Tumour Study Group and subsequently as Chair of the Children’s Oncology Group Renal Tumors Committee.  As Chair, he facilitated closer interactions with European-based colleagues in SIOP which led to collaborative studies. He was Director of the Division of Pedaitric Hematology and Oncology at the University of Alberta from 1999 to 2010. In this role, he was one of the founding members of C17, and served as the first Director of the C17 Research Committee. He subsequently served as Chair from 2006-2011. C17 now sponsors international clinical trials, develops and publishes evidence based guidelines for care and has overseen the development of communities of practice within childhood cancer for pharmacy, clinical research associates and nursing. From 2010 to 2015, Paul was Chief Program Officer and Senior Medical Director of CancerControl Alberta, Alberta Health Services.

Guillermo L Chantada.png

Professor Guillermo L Chantada

Central & South America

Professor Guillermo L Chantada, MD, PhD Is the current President of the International Society of Paediatric Oncologists 2023-2025. He is an associate member of the Oncology Service of the Hospital Saint Joan de Deu, Barcelona Spain, the Principal Researcher of the National Council of Research in Argentina (CONICET) and the Scientific Director at the Pediatric Hemato-Oncology Service of the Hospital Universitario Austral, Argentina and at the Hemato-oncology service of the Hospital Pereira Rossell in Montevideo, Uruguay. His major contributions are in the area of translational research in retinoblastoma where he worked in the identification of innovative treatments, the characteristics of this tumor in developing countries and in depicting its mechanisms of molecular dissemination. He leads the Latin American treatment protocol at the Grupo de America Latina de Oncologia Pediatrica (GALOP) where he is a member of the Board. He serves as Coordinator of the European Retinoblastoma Group (EURbG). He leads the development of an anti-idiotype vaccine for neuroblastoma in a Latin American protocol. Other areas of interest include pediatric lymphomas and histiocytosis. He is a member of the St. Jude Global Pediatric Medicine Department where he is Editor-in-Chief of Oncopedia at the Cure4Kids portal. He is a member of the board at the Latin American Society of Pediatric Oncology (SLAOP).

Angela Polenco

Angela Polanco


Angela Polanco PhD, NIHR MRes and NIHR Advanced Leadership Alumni, is the National Head of Public Engagement and Involvement for the NIHR CRN CC in the United Kingdom. The NIHR is funded by the Department of Health and Social Care to improve the health and wealth of the nation through research. Ms. Polenco is also the Senior Consumer Representative for NIHR Children’s Group. Polenco is an adept public involvement and engagement lead and the former founder and CEO of Bethany's Wish the UK based children's charity which advocated for those diagnosed with Nephroblastoma. She is a leading expert in developing and delivering PPI strategies for large organisations and was the lead for European PPI Childhood Cancer strategy project. She has authored a number of seminal international research papers and patient and public involvement and is regualrly chosen as the key PPI expert for international research funding panels and grant award committees. She has extensive experience in assessing quality, impact, feasibility and conducting peer review of scientific applications.